Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited
Public
Traded as BSE: 500420
Industry Pharmaceuticals
Founded 1959
Headquarters Ahmedabad, India
Key people
Sudhir Mehta
Revenue IncreaseINR 66 billion (March 2016)
IncreaseINR 17.5 billion (March 2016)
Number of employees
8600 (2014)
Website www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group. Based in the Indian city of Ahmedabad, it was promoted by U. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally.
Torrent Pharma is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Moreover, it has 7 fully owned subsidiares:

  1. Heumann Pharma GmbH & Co Generica KG, Germany
  2. Torrent Pharma GmbH, Germany
  3. Torrent do Brasil Ltda., Brazil
  4. ZAO Torrent Pharma, Russia
  5. Torrent Pharma Inc., United States
  6. Torrent Pharma Philippines Inc., Philippines
  7. Torrent Pharma Canada Inc., Canada

Torrent Pharmaceuticals acquired Heumann GmbH, a Pfizer group company in 2005.

Operations

The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Its operations locations are:

This article is issued from Wikipedia - version of the 12/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.